Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion
about
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearInsulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 SubjectsReduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.Randomized trial of infusion set function: steel versus teflon.Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusionMoving toward the ideal insulin for insulin pumps.Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.CSII: Longer Catheter Usage Time, a Reasonable Goal.Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.
P2860
Q35703026-F285D3DA-53A8-4D05-9B82-44F5902212A3Q35929406-A0EDFFDE-3AA8-433D-B3F0-06FE385F3443Q36340536-FBDE4282-2403-46C8-B64C-B202F19C0CF8Q36683272-24343CE3-E781-49AF-B206-24C5A07E1F09Q37062173-A9D4B940-FBCC-487E-BE5A-715C38F3ADDAQ37275651-A3D1B1D3-1125-44A2-834A-8E513919208FQ37460135-879B4B43-4B6A-4C1E-825B-F899B34CD39AQ37602674-4D5A9EAB-D676-43B7-85B0-091CB3C653FAQ38037730-1F8B8B48-10FE-43A0-BBE1-620CB4BF0664Q38631154-67653CE2-8A00-4304-A700-9AE90C757CC4Q38750029-FF70175D-4207-4403-AB61-7BDD09F7FEAAQ42482678-F975078B-756F-48F9-8956-D5FB318868E5Q51169744-4E0D7175-7462-45F3-9CBC-C70B6926001E
P2860
Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Consequences of delayed pump i ...... subcutaneous insulin infusion
@ast
Consequences of delayed pump i ...... subcutaneous insulin infusion
@en
type
label
Consequences of delayed pump i ...... subcutaneous insulin infusion
@ast
Consequences of delayed pump i ...... subcutaneous insulin infusion
@en
prefLabel
Consequences of delayed pump i ...... subcutaneous insulin infusion
@ast
Consequences of delayed pump i ...... subcutaneous insulin infusion
@en
P2093
P2860
P1476
Consequences of delayed pump i ...... subcutaneous insulin infusion
@en
P2093
C Lillian Yau
Haytham Kawji
Tilak Mallik
Tina K Thethi
Uwe Christians
Vivian Fonseca
P2860
P356
10.1016/J.JDIACOMP.2009.03.002
P577
2009-04-23T00:00:00Z